Position in MRNA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$297,697
+$79,765 QoQ
Shares Held
4,251
+30.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#440
of 772 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $4,501,972 across 8 Biotechnology names. MRNA ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
11,045 | $1,266,530 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,184 | $1,084,858 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
909 | $566,797 | |
| 4 | INCY |
Incyte Corp
|
4,483 | $508,192 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,786 | $430,372 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
4,251 | $297,697 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
919 | $276,646 | |
| 8 | FATE |
Fate Therapeutics Inc
|
26,252 | $70,880 |
All Filings in MRNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,697 | 4,251 | Shares | Sole | 2026-08-17 | |
| 2024-09-30 | $217,932 | 3,261 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $466,450 | 3,928 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $401,731 | 3,770 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $337,533 | 3,394 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $350,876 | 3,397 | Shares | Sole | 2023-10-18 | |
| 2021-12-31 | $248,646 | 979 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $381,781 | 992 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $257,773 | 1,097 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||